COVID-19News

HMD supplies 500 million of 0.5 ml AD syringes for covid vaccination

The next lot of 16.3 million syringes has been inspected and is ready to dispatch

Hindustan Syringes & Medical Devices (HMD) has achieved another milestone of supplying 500 million 0.5 ml AD syringes to the government to help vaccinate over 685 million people to date to support the massive vaccination campaign to eradicate COVID-19. The next lot of 16.3 million syringes has been inspected and is ready to dispatch.

THIS CAN BE YOUR ADVERTISEMENT

“In our endeavour to ensure there is no shortage of syringes to help vaccinate India against covid, HMD has preponed the supply commitments to the Ministry of Health and Family Welfare and has supplied 500 million pieces of KOJAK AD Syringes to the Government of India to help vaccinate over 685 million people. HMD presently is not accepting new business export opportunities from many overseas buyers and also had earlier diverted the supply of 100 million pieces from UNICEF order to GoI from September to December. HMD will always prioritise domestic needs, Sorry if it wasn’t enough. Regret Government has had to partly restrict exports, we all could have planned better,” shared Rajiv Nath, MD, HMD.

HMD is on track to produce and supply outstanding orders of 310 million 0.5 ml KOJAK AD Syringes by 2022 beginning, hopefully by January end.

HMD’s manufacturing plants are operational 24/7. It’s a race against time to help ramp up the capacity of our Cannulas (needle points) and needle capillary tubing manufacturing. A new 150,000 sq ft factory as a greenfield project is set to be commissioned by January 2022 to increase capacity from 4 billion Cannulas (needle points) per annum to 6 billion per annum. Presently, HMD is producing more than 4.25 lakh syringes of various types per hour at our factories spread over 11 acres in the Faridabad industrial district in Haryana.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close